Bio-pharmaceutical Industry in India to Expand 31.7% CAGR till 2023

Mumbai February 22, 2019 - Research on Global Markets has announced the addition of a market research report titled “Bio-pharmaceuticals Industry in India (2018-2023)” to their offering. According to the new report, the bio-pharmaceutical industry in India is predicted to expand a significant 31.7% on a compound annual growth rate (CAGR) basis to reach a value of INR 2,891.70 Bn in 2023. Currently, bio-pharmaceuticals is one of the fastest growing biotechnology segments in India and the country caters to nearly 50% of the global demand for pharmaceutical products, most of which are based on the usage of biotechnological applications.

The bio-pharmaceuticals industry analysis in India highlights the role of the government in the ‘Pharma Vision 2020’ initiative to ensure India emerge as a global leader in terms of end-to-end drug manufacturing. The Government of India has further approved an investment worth INR 15,000 Mn under the Innovate in India (i3) program for collaborating with industrial and academic organizations in the next five years to boost the bio-pharmaceutical production in the country.

Research on Global Markets tracks the performance of the major investors in the Indian bio-pharmaceutical market including AstraZeneca, Johnson & Johnson, GlaxoSmithKline (GSK), Nipro and Otsuka. The report also highlights the 46 mergers and acquisition (M&A) deals that were signed in the Indian bio-pharmaceutical market, generating business worth INR 94.77 Bn in 2017.

Key highlights of this report:

Bio-pharmaceuticals market definition and structure
Qualitative analysis of the drivers and challenges affecting the bio-pharmaceutical industry in India
Market size and growth forecast - value-wise (FY 2016-FY 2023e)
Market segmentation
Recent investments in the market
Government initiatives
Biotechnology and pharmaceutical research and development (R&D) hubs in India – overview

Export of bio-pharmaceuticals
Value-wise
Volume-wise
Country-wise

Import of bio-pharmaceuticals
Value-wise
Volume-wise
Country-wise

This report has been formulated and designed with the purpose of giving businesses a concise understanding of the demand for bio-pharmaceutical products across the world to determine the viability of the market, develop strategies based on the drivers, and to help brands identify competition and respond accordingly.

For more information, download Bio-pharmaceutical Industry in India:https://www.researchonglobalmarkets.com/bio-pharmaceuticals-industry-in-india-2018-2023.html

Owned by Netscribes, Research on Global Markets draws from the company’s vast experience in market research and intelligence. For any queries related to our products and services, feel free to get in touch with us at support@researchonglobalmarkets.com.

Please find below media contact for the releases:
Name: Ankita Basu
Email: support@researchonglobalmarkets.com
US Toll-Free: 18888313350
M: + 919903154956

41 East, 11th Street, New York, NY 10003, USA

This release was published on openPR.